ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,780,231 | +19.2% | 4,308,903 | +58.2% | 0.01% | +25.0% |
Q2 2023 | $97,154,885 | +39.3% | 2,724,478 | -0.8% | 0.01% | +166.7% |
Q1 2023 | $69,760,928 | -13.6% | 2,746,494 | +38.0% | 0.00% | -62.5% |
Q4 2022 | $80,695,459 | -0.3% | 1,989,533 | -18.8% | 0.01% | 0.0% |
Q3 2022 | $80,964,000 | -16.2% | 2,449,726 | -10.7% | 0.01% | -20.0% |
Q2 2022 | $96,580,000 | +50.2% | 2,742,968 | +96.1% | 0.01% | +100.0% |
Q1 2022 | $64,318,000 | -29.0% | 1,398,524 | +2.4% | 0.01% | -28.6% |
Q4 2021 | $90,591,000 | +9.0% | 1,366,377 | +2.6% | 0.01% | 0.0% |
Q3 2021 | $83,102,000 | -21.8% | 1,331,123 | +3.7% | 0.01% | -12.5% |
Q2 2021 | $106,335,000 | +22.2% | 1,283,929 | -2.1% | 0.01% | +14.3% |
Q1 2021 | $87,002,000 | -20.1% | 1,312,051 | -7.6% | 0.01% | -30.0% |
Q4 2020 | $108,947,000 | +33.6% | 1,419,876 | -25.0% | 0.01% | +25.0% |
Q3 2020 | $81,521,000 | -31.9% | 1,893,198 | -31.6% | 0.01% | -38.5% |
Q2 2020 | $119,620,000 | +46.9% | 2,769,622 | -2.1% | 0.01% | +18.2% |
Q1 2020 | $81,416,000 | -31.8% | 2,829,880 | +50.4% | 0.01% | -15.4% |
Q4 2019 | $119,338,000 | +212.6% | 1,881,408 | +38.9% | 0.01% | +160.0% |
Q3 2019 | $38,180,000 | +6.3% | 1,354,856 | +0.0% | 0.01% | +25.0% |
Q2 2019 | $35,901,000 | +14.2% | 1,354,758 | -20.9% | 0.00% | 0.0% |
Q1 2019 | $31,425,000 | +46.0% | 1,712,539 | -1.2% | 0.00% | +33.3% |
Q4 2018 | $21,522,000 | -43.2% | 1,732,845 | -12.4% | 0.00% | -25.0% |
Q3 2018 | $37,922,000 | – | 1,978,218 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |